Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Apr 10;1(2):95-98.
doi: 10.1016/j.ijwd.2015.01.006. eCollection 2015 Jun.

Excimer laser therapy and narrowband ultraviolet B therapy for exfoliative cheilitis

Affiliations

Excimer laser therapy and narrowband ultraviolet B therapy for exfoliative cheilitis

Bhavnit K Bhatia et al. Int J Womens Dermatol. .

Abstract

Background: Exfoliative cheilitis is a condition of unknown etiology characterized by hyperkeratosis and scaling of vermilion epithelium with cyclic desquamation. It remains largely refractory to treatment, including corticosteroid therapy, antibiotics, antifungals, and immunosuppressants.

Objective: We sought to evaluate the safety and efficacy of excimer laser therapy and narrowband ultraviolet B therapy in female patients with refractory exfoliative cheilitis.

Methods: We reviewed the medical records of two female patients who had been treated unsuccessfully for exfoliative cheilitis. We implemented excimer laser therapy, followed by hand-held narrowband UVB treatments for maintenance therapy, and followed them for clinical improvement and adverse effects.

Results: Both patients experienced significant clinical improvement with minimal adverse effects with excimer laser therapy 600-700 mJ/cm2 twice weekly for several months. The most common adverse effects were bleeding and burning, which occurred at higher doses. The hand-held narrowband UVB unit was also an effective maintenance tool.

Limitations: Limitations include small sample size and lack of standardization of starting dose and dose increments.

Conclusion: Excimer laser therapy is a well-tolerated and effective treatment for refractory exfoliative cheilitis with twice weekly laser treatments of up to 700 mJ/cm2. Transitioning to the hand-held narrowband UVB device was also an effective maintenance strategy.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
A, Exfoliative cheilitis. Patient 1 before beginning excimer laser therapy, with thick scaling and hyperkeratosis. B, Exfoliative cheilitis. Patient 1 showing significant improvement in scaling and dryness after completing 8 months of excimer therapy.
Fig. 2
Fig. 2
A, Exfoliative cheilitis. Patient 2 before beginning excimer therapy, demonstrating initial scaling and hypopigmentation. B, Exfoliative cheilitis. Patient 2 after 3 months of excimer laser therapy and 6 months of home narrowband UVB therapy, with minimal scaling and significant improvement of hypopigmentation.

References

    1. Almazrooa S.A., Woo S.B., Mawardi H., Treister N. Characterization and management of exfoliative cheilitis: a single-center experience. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;116(6):e485–e489. - PubMed
    1. Bianchi B., Campolmi P., Mavilia L., Danesi A., Rossi R., Cappugi P. Monochromatic excimer light (308 nm): an immunohistochemical study of cutaneous T cells and apoptosis-related molecules in psoriasis. J Eur Acad Dermatol Venereol. 2003;17(4):408–413. - PubMed
    1. Connolly M., Kennedy C. Exfoliative cheilitis successfully treated with topical tacrolimus. Br J Dermatol. 2004;151(1):241–242. - PubMed
    1. Crotty C.P., Dicken C.H. Factitious lip crusting. Arch Dermatol. 1981;117(6):338–340. - PubMed
    1. Daley T.D., Gupta A.K. Exfoliative cheilitis. J Oral Pathol Med. 1995;24(4):177–179. - PubMed

LinkOut - more resources